Our Celesq®-West IP Master Series continues. In this installment, Anthony F. Lo Cicero of Amster, Rothstein & Ebenstein discusses how the expansion of declaratory judgment jurisdiction after MedImune, and the emphasis on willfulness issues in the post-complaint environment after Seagate, have altered the way that companies can and should respond to patent demand letters.